CAS: 214559-60-1 - Bivatuzumab
Formula:Unspecified
- Synonyms:
- Bivatuzumab
- Immunoglobulin G1, anti-(human CD44v6 (antigen)) (human-mouse monoclonal BIWA4 γ1-chain), disulfide with human-mouse monoclonal BIWA4 κ-chain, dimer
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Bivatuzumab REF: TM-T77480CAS: 214559-60-1 | > 95% | 230.00 €~2,580.00 € | Tue 26 Nov 24 |
 | Bivatuzumab REF: 3D-CLA1214CAS: 214559-60-1 | - - - | To inquire | Tue 10 Dec 24 |
Bivatuzumab
CAS:214559-60-1
Bivatuzumab (BIWA 4) is a humanized monoclonal antibody against CD44v6.
Purity:
> 95%
Color and Shape:
Liquid
Ref: TM-T77480
| 1mg | 230.00 € | ||
| 5mg | 603.00 € | ||
| 10mg | 916.00 € | ||
| 25mg | 1,430.00 € | ||
| 50mg | 1,838.00 € | ||
| 100mg | 2,580.00 € |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Bivatuzumab
CAS:214559-60-1
Humanized anti-CD44 v6 monoclonal antibody; used in radiotherapy when linked to radioisotopes
Ref: 3D-CLA1214
| Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
